Prostate Cancer

Journal Title：Prostate Cancer

Prostate Cancer is an international peer-reviewed open access journal dedicated to prostate cancer research, providing a multidisciplinary platform for medical professionals to share and exchange the latest scientific research in the field of prostate cancer. The publication of the journal reflects the importance of prostate cancer as one of the major threats to men's health and the urgent need for further research in this area.

The reader and author community of the journal includes urologists, oncologists, radiation oncologists, pathologists, biomedical researchers, and scholars and students in related fields. By publishing original research, review articles, and clinical studies, the journal promotes not only the basic science of prostate cancer, but also the innovation and improvement of clinical treatment strategies. It covers everything from molecular biology, genetics, and epidemiological studies to clinical trials, evaluation of treatment outcomes, and patient management. It pays special attention to the early diagnosis of prostate cancer, precision treatment, improvement of patients' quality of life and long-term follow-up research, aiming to improve the comprehensive understanding of prostate cancer occurrence, development and treatment through interdisciplinary cooperation.

《前列腺癌》是一本致力于前列腺癌研究的国际同行评审开放获取期刊，它为广大医学专业人士提供了一个分享和交流前列腺癌领域最新科研成果的多学科平台。该期刊的出版，反映了前列腺癌作为男性健康主要威胁之一的重要性，以及对这一领域深入研究的迫切需求。

期刊的读者和作者群体包括泌尿外科医生、肿瘤科医生、放射肿瘤学家、病理学家、生物医学研究人员以及相关领域的学者和学生。通过发表原创研究、综述文章和临床研究，该期刊不仅促进了前列腺癌基础科学的发展，也推动了临床治疗策略的创新和改进。内容覆盖了从分子生物学、遗传学、流行病学研究到临床试验、治疗结果评估和患者管理等多个方面。它特别关注前列腺癌的早期诊断、精准治疗、患者生活质量的提升以及长期跟踪研究，旨在通过跨学科合作，提高对前列腺癌发生、发展和治疗的全面认识。

Prostate Cancer由Hindawi Limited出版商出版，收稿方向涵盖ONCOLOGY全领域，平均审稿速度 13 Weeks ，影响因子指数2.3，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。